According to Basilea Pharmaceutica's latest financial reports the company's current revenue (TTM ) is ยฃ0.17 Billion. In 2024 the company made a revenue of ยฃ0.17 Billion an increase over the revenue in the year 2023 that were of ยฃ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | ยฃ0.17 B | 23.14% |
2023 | ยฃ0.13 B | 17.22% |
2022 | ยฃ0.11 B | -1.33% |
2021 | ยฃ0.12 B | 11.98% |
2020 | ยฃ0.10 B | 4.35% |
2019 | ยฃ0.10 B | 2.94% |
2018 | ยฃ99.89 M | 29.26% |
2017 | ยฃ77.28 M | 60.96% |
2016 | ยฃ48.01 M | 21.15% |
2015 | ยฃ39.63 M | 23.97% |
2014 | ยฃ31.96 M | -7.52% |
2013 | ยฃ34.56 M | -27.04% |
2012 | ยฃ47.38 M | -10.3% |
2011 | ยฃ52.82 M | -42.37% |
2010 | ยฃ91.66 M | 398.6% |
2009 | ยฃ18.38 M | 116% |
2008 | ยฃ8.51 M | 58.28% |
2007 | ยฃ5.37 M | 22.85% |
2006 | ยฃ4.37 M | -74.52% |
2005 | ยฃ17.17 M | 9119.33% |
2004 | ยฃ0.18 M | -18.03% |
2003 | ยฃ0.22 M | 19.15% |
2002 | ยฃ0.19 M |